Skip to main content

Management of Metastatic, Recurrent, and Unusual Cervical Cancer

  • Reference work entry
  • First Online:
Handbook of Gynecology

Abstract

Treatment guidelines for uterine cervical cancer have been established based on the findings of randomized clinical trials conducted in the past few decades. Although most cases of cervical cancer can be adequately managed with standard treatments, problems can arise in cases involving unusual presentations. Metastatic and recurrent cervical cancers are considered to be incurable. Although attempts have been made to treat patients with metastatic or recurrent cervical cancer with a variety of approaches including chemotherapy, radiotherapy, and surgery (as monotherapies or in combination), such patients have a dismal prognosis, with a reported 5-year survival rate of <10%. In this chapter, we first review the current management strategies for metastatic or recurrent cervical cancer. Then, we review the management strategies for unusual cases of cervical cancer, such as those involving the incidental detection of cervical cancer during pregnancy or in hysterectomy specimens, bulky lymph nodes, cervical stump cancer, cervical bleeding or ureteral obstruction, or unusual cervical cancer cell types.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Al-Halal H, Kezouh A, Abenhaim HA. Incidence and obstetrical outcomes of cervical intraepithelial neoplasia and cervical cancer in pregnancy: a population-based study on 8.8 million births. Arch Gynecol Obstet. 2013;287(2):245–50.

    Article  PubMed  Google Scholar 

  • Amant F, Halaska MJ, Fumagalli M, Dahl Steffensen K, Lok C, Van Calsteren K, Han SN, Mir O, Fruscio R, Uzan C, Maxwell C, Dekrem J, Strauven G, Mhallem Gziri M, Kesic V, Berveiller P, van den Heuvel F, Ottevanger PB, Vergote I, Lishner M, Morice P, Nulman I, Pregnancy’ EtfCi. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014;24(3):394–403.

    Article  PubMed  Google Scholar 

  • Ayhan A, Otegen U, Guven S, Kucukali T. Radical reoperation for invasive cervical cancer found in simple hysterectomy. J Surg Oncol. 2006;94(1):28–34.

    Article  PubMed  Google Scholar 

  • Badakh DK, Grover AH. Reirradiation with high-dose-rate remote afterloading brachytherapy implant in patients with locally recurrent or residual cervical carcinoma. J Cancer Res Ther. 2009;5(1):24–30.

    Article  PubMed  Google Scholar 

  • Bansal S, Lewin SN, Burke WM, Deutsch I, Sun X, Herzog TJ, Wright JD. Sarcoma of the cervix: natural history and outcomes. Gynecol Oncol. 2010;118(2):134–8.

    Article  PubMed  Google Scholar 

  • Berek JS, Howe C, Lagasse LD, Hacker NF. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol. 2005;99(1):153–9.

    Article  PubMed  Google Scholar 

  • Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer. 1948;1(2):177–83.

    Article  CAS  PubMed  Google Scholar 

  • Charra C, Roy P, Coquard R, Romestaing P, Ardiet JM, Gérard JP. Outcome of treatment of upper third vaginal recurrences of cervical and endometrial carcinomas with interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40(2):421–6.

    Article  CAS  PubMed  Google Scholar 

  • Chen J, Macdonald OK, Gaffney DK. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix. Obstet Gynecol. 2008;111(6):1394–402.

    Article  PubMed  Google Scholar 

  • Cherry CP, Glucksmann A. Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix. Cancer. 1956;9(5):971–9.

    Article  CAS  PubMed  Google Scholar 

  • Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Ferrandina G, Legge F, Parazzini F, Scambia G, Schneider A, Vercellino GF. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. Int J Gynecol Cancer. 2014;24(5):916–22.

    Article  PubMed  Google Scholar 

  • Chopra S, Mangaj A, Sharma A, Tan LT, Sturdza A, Jürgenliemk-Schulz I, Han K, Huang F, Schmid MP, Fokdal L, Chargari C, Diendorfer T, Tanderup K, Potter R, Nout RA. Management of oligo-metastatic and oligo-recurrent cervical cancer: a pattern of care survey within the EMBRACE research network. Radiother Oncol. 2021;155:151–9.

    Article  CAS  PubMed  Google Scholar 

  • Chung HC, Ros W, Delord JP, Perets R, Italiano A, Shapira-Frommer R, Manzuk L, Piha-Paul SA, Xu L, Zeigenfuss S, Pruitt SK, Leary A. Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol. 2019;37:1470–8.

    Article  CAS  PubMed  Google Scholar 

  • Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, Osann K, Chan JK. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol. 2010;203(4):347.e341–6.

    Article  Google Scholar 

  • Cosin JA, Fowler JM, Chen MD, Paley PJ, Carson LF, Twiggs LB. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer. 1998;82(11):2241–8.

    Article  CAS  PubMed  Google Scholar 

  • Duggan B, Muderspach LI, Roman LD, Curtin JP, d’Ablaing G, Morrow CP. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet Gynecol. 1993;82(4 Pt 1):598–602.

    CAS  PubMed  Google Scholar 

  • Fadare O, Ghofrani M, Stamatakos MD, Tavassoli FA. Mesenchymal lesions of the uterine cervix. Pathol Case Rev. 2006;11(3):140–52.

    Article  Google Scholar 

  • Frenel JS, Le Tourneau C, O’Neil B, Ott PA, Piha-Paul SA, Gomez-Roca C, van Brummelen EMJ, Rugo HS, Thomas S, Saraf S, Rangwala R, Varga A. Safety and efficacy of Pembrolizumab in advanced, programmed death ligand 1-positive cervical cancer: results from the phase Ib KEYNOTE-028 trial. J Clin Oncol. 2017;35(36):4035–41.

    Article  CAS  PubMed  Google Scholar 

  • Geijteman ECT, Wensveen CWM, Duvekot JJ, van Zuylen L. A child with severe hearing loss associated with maternal cisplatin treatment during pregnancy. Obstet Gynecol. 2014;124(2 Pt 2 Suppl 1):454–6.

    Article  PubMed  Google Scholar 

  • Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol. 1989;13:717–29.

    Article  CAS  PubMed  Google Scholar 

  • Goldberg GL, Sukumvanich P, Einstein MH, Smith HO, Anderson PS, Fields AL. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center experience (1987 to 2003). Gynecol Oncol. 2006;101(2):261–8.

    Article  PubMed  Google Scholar 

  • Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: phase II study of the Radiation Therapy Oncology Group 92–10. Int J Radiat Oncol Biol Phys. 1998;41(4):817–22.

    Article  CAS  PubMed  Google Scholar 

  • Guitarte C, Alagkiozidis I, Mize B, Stevens E, Salame G, Lee YC. Glassy cell carcinoma of the cervix: a systematic review and meta-analysis. Gynecol Oncol. 2014;133(2):186–91.

    Article  PubMed  Google Scholar 

  • Gusserow ALS. Ueber sarcome des uterus. Arch Gynakol. 1870;1:240–51.

    Article  Google Scholar 

  • Halaska MJ, Uzan C, Han SN, Fruscio R, Dahl Steffensen K, Van Calster B, Stankusova H, Delle Marchette M, Mephon A, Rouzier R, Witteveen PO, Vergani P, Van Calsteren K, Rob L, Amant F. Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy. Int J Gynecol Cancer. 2019:ijgc-2018-000103. https://doi.org/10.1136/ijgc-2018-000103.

  • Hellström AC, Sigurjonson T, Pettersson F. Carcinoma of the cervical stump. The radiumhemmet series 1959–1987. Treatment and prognosis. Acta Obstet Gynecol Scand. 2001;80(2):152–7.

    Article  PubMed  Google Scholar 

  • Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284(15):878–81.

    Article  CAS  PubMed  Google Scholar 

  • Hopkins MP, Peters WA, Andersen W, Morley GW. Invasive cervical cancer treated initially by standard hysterectomy. Gynecol Oncol. 1990;36(1):7–12.

    Article  CAS  PubMed  Google Scholar 

  • Kamath GD, Bhatt A, Ramaswamy V. A rare case of adenoma malignum: preparing for the unforeseen. J Obstet Gynaecol India. 2017;67(1):70–3.

    Article  PubMed  Google Scholar 

  • Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG, Froelich JW, Gilk T, Gimbel JR, Gosbee J, Kuhni-Kaminski E, Lester JW, Nyenhuis J, Parag Y, Schaefer DJ, Sebek-Scoumis EA, Weinreb J, Zaremba LA, Wilcox P, Lucey L, Sass N, Safety ABRPoM. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol. 2007;188(6):1447–74.

    Article  PubMed  Google Scholar 

  • Kim YM, Jung MH, Kim DY, Kim JH, Kim YT, Nam JH. Small cell carcinoma of the uterine cervix: clinicopathologic study of 20 cases in a single center. Eur J Gynaecol Oncol. 2009;30(5):539–42.

    CAS  PubMed  Google Scholar 

  • Kim HJ, Chang JS, Koom WS, Lee KC, Kim GE, Kim YB. Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer. Gynecol Oncol. 2018;151(2):208–14.

    Article  PubMed  Google Scholar 

  • Kojima A, Mikami Y, Sudo T, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol. 2007;31:664–72.

    Article  PubMed  Google Scholar 

  • Kuji S, Hirashima Y, Nakayama H, Nishio S, Otsuki T, Nagamitsu Y, Tanaka N, Ito K, Teramoto N, Yamada T. Diagnosis, clinicopathologic features, treatment, and prognosis of small cell carcinoma of the uterine cervix; Kansai Clinical Oncology Group/Intergroup study in Japan. Gynecol Oncol. 2013;129(3):522–7.

    Article  PubMed  Google Scholar 

  • Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. Lyon: IARC Press; 2014.

    Google Scholar 

  • Leath CA, Straughn JM. Chemotherapy for advanced and recurrent cervical carcinoma: results from cooperative group trials. Gynecol Oncol. 2013;129(1):251–7.

    Article  CAS  PubMed  Google Scholar 

  • Lee JM, Lee KB, Nam JH, Ryu SY, Bae DS, Park JT, Kim SC, Cha SD, Kim KR, Song SY, Kang SB. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study. Ann Oncol. 2008;19(2):321–6.

    Article  PubMed  Google Scholar 

  • Lee MH, Kim ES, Choi MC, et al. Minimal deviation adenocarcinoma (adenoma malignum) of the uterine cervix: clinicopathological analysis of 17 cases. Obstet Gynecol Sci. 2018;61:590–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Li G, Jiang W, Gui S, Xu C. Minimal deviation adenocarcinoma of the uterine cervix. Int J Gynaecol Obstet. 2010;110(2):89–92.

    Article  PubMed  Google Scholar 

  • Li M, Zhao Y, Qie M, Zhang Y, Li L, Lin B, Guo R, You Z, An R, Liu J, Zhang Z, Bi H, Hong Y, Chang S, He G, Hua K, Zhou Q, Liao Q, Wang Y, Wang J, Li X, Wei L. Management of cervical cancer in pregnant women: a multi-center retrospective study in China. Front Med (Lausanne). 2020;7:538815. https://doi.org/10.3389/fmed.2020.538815.

    Article  PubMed  Google Scholar 

  • Luke JJ, Flaherty KT, Ribas A, Long GV. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017;14(8):463–82.

    Article  CAS  PubMed  Google Scholar 

  • Mabuchi S, Takahashi R, Isohashi F, Yokoi T, Okazawa M, Sasano T, Maruoka S, Anzai M, Yoshioka Y, Ogawa K, Kimura T. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience. Int J Gynecol Cancer. 2014;24(1):141–8.

    Article  PubMed  Google Scholar 

  • Mabuchi S, Kozasa K, Kimura T. Radical hysterectomy after radiotherapy for recurrent or persistent cervical cancer. Int J Gynaecol Obstet. 2017;139:185–91.

    Article  PubMed  Google Scholar 

  • Mabuchi S, Yamamoto M, Murata H, Yokoe T, Hamanishi J, Terai Y, Imatake H, Mabuchi Y, Mori T, Kitada F, Hashiguchi Y, Takahashi A, Fujiwara S, Naoi H, Matsubara S. Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district. Japan Int J Clin Oncol. 2021a;26(3):598–605.

    Google Scholar 

  • Mabuchi S, Shimura K, Matsumoto Y. The significance of post-radiotherapy parametrial involvement and the necessity of parametrial resection in locally-recurrent or persistent cervical cancer developed after radiotherapy. J Gynecol Obstet Hum Reprod. 2021b;50(10):102190. https://doi.org/10.1016/j.jogoh.2021.102190.

  • Maneo A, Landoni F, Cormio G, Colombo A, Mangioni C. Radical hysterectomy for recurrent or persistent cervical cancer following radiation therapy. Int J Gynecol Cancer. 1999;9(4):295–301.

    Article  PubMed  Google Scholar 

  • Marnitz S, Köhler C, Müller M, Behrens K, Hasenbein K, Schneider A. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol. 2006;103(3):1023–30.

    Article  PubMed  Google Scholar 

  • McCusker ME, Coté TR, Clegg LX, Tavassoli FJ. Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecol Oncol. 2003;88(3):333–9.

    Article  PubMed  Google Scholar 

  • Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, Benda J, Cella D. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2009;27(28):4649–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mordel N, Mor-Yosef S, Ben-Baruch N, et al. Malignant melanoma of the uterine cervix: case report and review of the literature. Gynecol Oncol. 1989;32:375–80.

    Article  CAS  PubMed  Google Scholar 

  • Morice P, Uzan C, Gouy S, Verschraegen C, Haie-Meder C. Gynaecological cancers in pregnancy. Lancet. 2012;379(9815):558–69.

    Article  PubMed  Google Scholar 

  • Nishio S, Mikami Y, Tokunaga H, Yaegashi N, Satoh T, Saito M, Okamoto A, Kasamatsu T, Miyamoto T, Shiozawa T, Yoshioka Y, Mandai M, Kojima A, Takehara K, Kaneki E, Kobayashi H, Kaku T, Ushijima K, Kamura T. Analysis of gastric-type mucinous carcinoma of the uterine cervix – an aggressive tumor with a poor prognosis: a multi-institutional study. Gynecol Oncol. 2019;153(1):13–9.

    Article  PubMed  Google Scholar 

  • Park SB, Moon MH, Hong SR, Lee MS, Cho HC, Han BH, Lim KT. Adenoma malignum of the uterine cervix: ultrasonographic findings in 11 patients. Ultrasound Obstet Gynecol. 2011;38(6):716–21.

    Article  CAS  PubMed  Google Scholar 

  • Pradhan TS, Duan H, Katsoulakis E, Salame G, Lee YC, Abulafia O. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer. Int J Gynecol Cancer. 2011;21(6):1091–6.

    Article  PubMed  Google Scholar 

  • Prempree T, Kwon T, VillaSanta U, Scott RM. Management of late second or late recurrent squamous cell carcinoma of the cervix uteri after successful initial radiation treatment. Int J Radiat Oncol Biol Phys. 1979;5(11–12):2053–7.

    Article  CAS  PubMed  Google Scholar 

  • Pusceddu S, Bajetta E, Carcangiu ML, Formisano B, Ducceschi M, Buzzoni R. A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer. Crit Rev Oncol Hematol. 2012;81(2):185–95.

    Article  PubMed  Google Scholar 

  • Randall ME, Evans L, Greven KM, McCunniff AJ, Doline RM. Interstitial reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors. Gynecol Oncol. 1993;48(1):23–31.

    Article  CAS  PubMed  Google Scholar 

  • Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016;316(9):952–61.

    Article  PubMed  Google Scholar 

  • Redondo A, Colombo N, McCormack M, Dreosti L, Nogueira-Rodrigues A, Scambia G, Lorusso D, Joly F, Schenker M, Ruff P, Estevez-Diz M, Irahara N, Donica M, Gonzalez-Martín A. Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer. Gynecol Oncol. 2020;159(1):142–9.

    Article  CAS  PubMed  Google Scholar 

  • Rob L, Skapa P, Robova H. Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol. 2011;12(2):192–200.

    Article  PubMed  Google Scholar 

  • Rose PG, Ali S, Whitney CW, Lanciano R, Stehman FB. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol. 2010;117(2):270–5.

    Article  PubMed  Google Scholar 

  • Rutledge S, Carey MS, Prichard H, Allen HH, Kocha W, Kirk ME. Conservative surgery for recurrent or persistent carcinoma of the cervix following irradiation: is exenteration always necessary? Gynecol Oncol. 1994;52:353–9.

    Article  CAS  PubMed  Google Scholar 

  • Satoh T, Takei Y, Treilleux I, Devouassoux-Shisheboran M, Ledermann J, Viswanathan AN, Mahner S, Provencher DM, Mileshkin L, Åvall-Lundqvist E, Pautier P, Reed NS, Fujiwara K. Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S102–8.

    Article  PubMed  Google Scholar 

  • Schmidt AM, Imesch P, Fink D, Egger H. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol. 2012;125(3):604–9.

    Article  PubMed  Google Scholar 

  • SEER Stat Fact: Cervix Uteri Cancer. Available from http://seer.cancer.gov/statfacts/html/cervix.html. Accessed Apr 2022

  • Silverberg SG, Hurt WG. Minimal deviation adenocarcinoma (“adenoma malignum”) of the cervix: a reappraisal. Am J Obstet Gynecol. 1975;121:971–5.

    Article  CAS  PubMed  Google Scholar 

  • Stanca M, Ciobanu V, Gheorghe M, Kiss SL, Cozlea AL, Căpîlna ME. The double life-saving approach of abdominal radical trachelectomy during pregnancy for early-stage cervical cancer – an overview of the literature and our institutional experience. J Pers Med. 2021;11(1):29. https://doi.org/10.3390/jpm11010029.

    Article  PubMed  PubMed Central  Google Scholar 

  • Szánthó A, Bálega JJ, Csapó Z, Sréter LL, Matolcsy A, Papp Z. Primary non-Hodgkin’s lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report. Gynecol Oncol. 2003;89(1):171–4.

    Article  PubMed  Google Scholar 

  • Takushi M, Moromizato H, Sakumoto K, Kanazawa K. Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment. Gynecol Oncol. 2002;87(2):185–9.

    Article  PubMed  Google Scholar 

  • Tewari KS, Sill MW, Long HJ, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370(8):734–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thomas MB, Wright JD, Leiser AL, Chi DS, Mutch DG, Podratz KC, Dowdy SC. Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era. Gynecol Oncol. 2008;109(3):335–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tian WJ, Zhang MQ, Shui RH. Prognostic factors and treatment comparison in early-stage small cell carcinoma of the uterine cervix. Oncol Lett. 2012;3(1):125–30.

    Article  CAS  PubMed  Google Scholar 

  • Upanal N, Enjeti A. Primary lymphoma of the uterus and cervix: two case reports and review of the literature. Aust N Z J Obstet Gynaecol. 2011;51(6):559–62.

    Article  PubMed  Google Scholar 

  • van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378(9804):1741–55.

    Article  PubMed  Google Scholar 

  • Vang R, Medeiros LJ, Ha CS, Deavers M. Non-Hodgkin’s lymphomas involving the uterus: a clinicopathologic analysis of 26 cases. Mod Pathol. 2000;13(1):19–28.

    Article  CAS  PubMed  Google Scholar 

  • Varia MA, Bundy BN, Deppe G, Mannel R, Averette HE, Rose PG, Connelly P. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys. 1998;42(5):1015–23.

    Article  CAS  PubMed  Google Scholar 

  • Wang KL, Chang TC, Jung SM, Chen CH, Cheng YM, Wu HH, Liou WS, Hsu ST, Ou YC, Yeh LS, Lai HC, Huang CY, Chen TC, Chang CJ, Lai CH. Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: a Taiwanese Gynecologic Oncology Group study. Eur J Cancer. 2012;48(10):1484–94.

    Article  PubMed  Google Scholar 

  • Yoo HJ, Lim MC, Seo SS, Kang S, Yoo CW, Kim JY, Park SY. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea. J Gynecol Oncol. 2012;23(4):242–50.

    Article  PubMed  PubMed Central  Google Scholar 

  • Yoon HI, Cha J, Keum KC, Lee HY, Nam EJ, Kim SW, Kim S, Kim YT, Kim GE, Kim YB. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis. Radiat Oncol. 2015;10(1):18.

    Article  PubMed  PubMed Central  Google Scholar 

  • Zagouri F, Sergentanis TN, Chrysikos D, Bartsch R. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013;121(2 Pt 1):337–43.

    Article  CAS  PubMed  Google Scholar 

  • Zemlickis D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Maternal and fetal outcome after invasive cervical cancer in pregnancy. J Clin Oncol. 1991;9(11):1956–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seiji Mabuchi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Mabuchi, S., Kawano, M., Takahashi, R., Kuroda, H. (2023). Management of Metastatic, Recurrent, and Unusual Cervical Cancer. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-031-14881-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-14881-1_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-14880-4

  • Online ISBN: 978-3-031-14881-1

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics